🦴 Could a key immune pathway help explain why bones weaken with age?

A new study published in Advanced Science identifies a connection between aging bone marrow fat cells, inflammatory signaling and reduced bone formation. In mice, researchers found that combining a STING inhibitor with NMN supplementation helped slow bone loss and improve several measures of bone health.

The findings offer a promising direction for osteoporosis research, but human studies are still needed to determine whether this approach could become a safe and effective treatment.

🔬 Discover how inflammation and cellular metabolism may work together to influence skeletal aging.

AI, banking, semiconductors and interest rates are all sending important signals to financial markets. 🇺🇸

📈 From the U.S. AI investment boom and accelerating bank mergers to a $21 billion Japan-U.S. semiconductor project and new Bank of England rate guidance, several major forces are shaping the global investment landscape. Here’s what investors should know.

new Game 👇😍
----------------
Fruit Merge Reloaded

Little fruits fall, big fruits rise, match them right for a juicy surprise. Stack too high and it all comes down, Fruit Merge Reloaded: the sweetest puzzle in town!

Elvin Pro - Ölsem Bağışla | Yeni

📈 Wall Street's latest moves reveal a market divided!

The Dow climbed 0.49% by late morning on October 12, while the S&P 500 and Nasdaq slipped as technology stocks faced pressure. Meanwhile, Brent crude rose above $106 per barrel, raising fresh questions about inflation and borrowing costs.

Investors are now watching September inflation data, retail sales and major bank earnings for clues about where markets could head next.

Will economic data calm investors—or keep markets on edge? Follow the key developments as the week unfolds.

[Disclaimer:
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice
The content shared in economics articles is solely for research and informational purposes.
We are not a financial advisory service, and the information provided should not be considered investment or trading advice.]